BTVPUR AlSap 1

RSS

Withdrawn

This medicine's authorisation has been withdrawn

bluetongue-virus serotype-1 antigen
MedicineVeterinaryWithdrawn

Czech is available via eTranslation, the European Commission's machine translation service.

Translate to Czech | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for BTVPUR AlSap 1 has been withdrawn at the request of the marketing-authorisation holder.

български (BG) (273.86 KB - PDF)

Zobrazit

español (ES) (219.81 KB - PDF)

Zobrazit

čeština (CS) (279.88 KB - PDF)

Zobrazit

dansk (DA) (215.41 KB - PDF)

Zobrazit

Deutsch (DE) (241.24 KB - PDF)

Zobrazit

eesti (ET) (244.85 KB - PDF)

Zobrazit

ελληνικά (EL) (281.98 KB - PDF)

Zobrazit

français (FR) (242.72 KB - PDF)

Zobrazit

italiano (IT) (215.09 KB - PDF)

Zobrazit

latviešu (LV) (257.92 KB - PDF)

Zobrazit

lietuvių (LT) (242.99 KB - PDF)

Zobrazit

magyar (HU) (257.59 KB - PDF)

Zobrazit

Malti (MT) (287.39 KB - PDF)

Zobrazit

Nederlands (NL) (215.61 KB - PDF)

Zobrazit

polski (PL) (262.68 KB - PDF)

Zobrazit

português (PT) (215.81 KB - PDF)

Zobrazit

română (RO) (264.84 KB - PDF)

Zobrazit

slovenčina (SK) (263.85 KB - PDF)

Zobrazit

slovenščina (SL) (271.89 KB - PDF)

Zobrazit

suomi (FI) (214.4 KB - PDF)

Zobrazit

svenska (SV) (215.45 KB - PDF)

Zobrazit

Product information

български (BG) (1.59 MB - PDF)

Zobrazit

español (ES) (959.08 KB - PDF)

Zobrazit

čeština (CS) (1.31 MB - PDF)

Zobrazit

dansk (DA) (976.46 KB - PDF)

Zobrazit

Deutsch (DE) (1.05 MB - PDF)

Zobrazit

eesti (ET) (962.08 KB - PDF)

Zobrazit

ελληνικά (EL) (1.63 MB - PDF)

Zobrazit

français (FR) (969.67 KB - PDF)

Zobrazit

hrvatski (HR) (995.44 KB - PDF)

Zobrazit

italiano (IT) (409.73 KB - PDF)

Zobrazit

latviešu (LV) (588.19 KB - PDF)

Zobrazit

lietuvių (LT) (480.92 KB - PDF)

Zobrazit

magyar (HU) (1.31 MB - PDF)

Zobrazit

Malti (MT) (596.85 KB - PDF)

Zobrazit

Nederlands (NL) (355.82 KB - PDF)

Zobrazit

polski (PL) (595.12 KB - PDF)

Zobrazit

português (PT) (421.48 KB - PDF)

Zobrazit

română (RO) (479.93 KB - PDF)

Zobrazit

slovenčina (SK) (582.8 KB - PDF)

Zobrazit

slovenščina (SL) (563.67 KB - PDF)

Zobrazit

suomi (FI) (942.5 KB - PDF)

Zobrazit

svenska (SV) (419.01 KB - PDF)

Zobrazit

Íslenska (IS) (1.21 MB - PDF)

Zobrazit

norsk (NO) (410.45 KB - PDF)

Zobrazit
Latest procedure affecting product information:R/0005
08/09/2015

български (BG) (237.24 KB - PDF)

Zobrazit

español (ES) (179.61 KB - PDF)

Zobrazit

čeština (CS) (214.8 KB - PDF)

Zobrazit

dansk (DA) (168.71 KB - PDF)

Zobrazit

Deutsch (DE) (181.32 KB - PDF)

Zobrazit

eesti (ET) (216.18 KB - PDF)

Zobrazit

ελληνικά (EL) (224.9 KB - PDF)

Zobrazit

français (FR) (168.45 KB - PDF)

Zobrazit

hrvatski (HR) (203.36 KB - PDF)

Zobrazit

italiano (IT) (166.05 KB - PDF)

Zobrazit

latviešu (LV) (222.44 KB - PDF)

Zobrazit

lietuvių (LT) (215.2 KB - PDF)

Zobrazit

magyar (HU) (208.44 KB - PDF)

Zobrazit

Malti (MT) (226.37 KB - PDF)

Zobrazit

Nederlands (NL) (169.29 KB - PDF)

Zobrazit

polski (PL) (215.44 KB - PDF)

Zobrazit

português (PT) (180.94 KB - PDF)

Zobrazit

română (RO) (212.26 KB - PDF)

Zobrazit

slovenčina (SK) (211.23 KB - PDF)

Zobrazit

slovenščina (SL) (210.68 KB - PDF)

Zobrazit

suomi (FI) (168.59 KB - PDF)

Zobrazit

svenska (SV) (168.12 KB - PDF)

Zobrazit

Íslenska (IS) (171.81 KB - PDF)

Zobrazit

norsk (NO) (166.89 KB - PDF)

Zobrazit

Product details

Name of medicine
BTVPUR AlSap 1
Active substance
bluetongue-virus serotype-1 antigen
International non-proprietary name (INN) or common name
bluetongue-virus serotype-1 antigen
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI04AA02

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.

Onset of immunity has been demonstrated three weeks after the primary vaccination course. The duration of immunity for cattle and sheep is one year after the primary vaccination course.

Authorisation details

EMA product number
EMEA/V/C/002230
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
17/12/2010
Revision
4

Assessment history

This page was last updated on

Share this page